Literature DB >> 2015720

Primary CNS malignant rhabdoid tumor (MRT): report of two cases and review of literature.

S M Chou1, J S Anderson.   

Abstract

Primary CNS rhabdoid tumor is an enigmatic and extremely rare malignant tumor of early childhood, probably embryonal, that has often been histopathologically classified together with rhabdoid tumor of kidneys or other organs in infants. Only four previously documented cases of primary CNS malignant rhabdoid tumor (MRT) were found in the literature. We report two cases of primary CNS MRT with biopsy and complete autopsy findings that share close clinicopathologic, immunohistochemical and ultrastructural similarities between the two. It is concluded that the primary CNS MRT is an entity which is extremely malignant, easily mistaken as a primitive neuroectodermal tumor, and potentially derives from a meningothelial precursor cell which is embryonally equal to the serosal mesothelial precursor cells which surround the kidneys and other organs. Hence, it tends to anatomically occur at the location of abundant meningeal infoldings such as the cerebellar cortex and may be diffuse or multicentric in its meningeal involvement. Furthermore, it may concurrently or multicentrically occur in association with MRT originating from the serosal membrane of other organs, such as the kidney.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2015720

Source DB:  PubMed          Journal:  Clin Neuropathol        ISSN: 0722-5091            Impact factor:   1.368


  18 in total

1.  Pleomorphic primitive neuroectodermal tumor with glial and neuronal differentiation: clinical, pathological, cultural, and chromosomal analysis of a case.

Authors:  Yuji Uematsu; Rie Takehara; Mina Shimizu; Yoshiyuki Tanaka; Toru Itakura; Norihiko Komai
Journal:  J Neurooncol       Date:  2002-08       Impact factor: 4.130

2.  Atypical teratoid/rhabdoid tumor of the cerebellum: report of two infantile cases.

Authors:  Young Kyung Lee; Choong Gon Choi; Jeong Hyun Lee
Journal:  AJNR Am J Neuroradiol       Date:  2004-03       Impact factor: 3.825

3.  Malignant rhabdoid tumor: primary intracranial manifestation in an adult.

Authors:  M Horn; W Schlote; K D Lerch; W I Steudel; D Harms; E Thomas
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

4.  Imaging findings in primary intracranial atypical teratoid/rhabdoid tumors.

Authors:  Hemant Parmar; Cynthia Hawkins; Eric Bouffet; James Rutka; Manohar Shroff
Journal:  Pediatr Radiol       Date:  2005-12-08

5.  Malignant rhabdoid tumor of the small intestine in an adult: a case report with immunohistochemical and ultrastructural findings.

Authors:  Y Chen; S M Jung; T C Chao
Journal:  Dig Dis Sci       Date:  1998-05       Impact factor: 3.199

6.  Primary malignant rhabdoid tumors of the central nervous system: considerations about two cases of adulthood presentation.

Authors:  José Pimentel; Rita Silva; Teresa Pimentel
Journal:  J Neurooncol       Date:  2003-01       Impact factor: 4.130

Review 7.  Clinicopathologic and cytogenetic analysis of malignant rhabdoid tumor of the central nervous system.

Authors:  R P Hasserjian; R D Folkerth; R M Scott; D E Schofield
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

Review 8.  Continuous remission of newly diagnosed and relapsed central nervous system atypical teratoid/rhabdoid tumor.

Authors:  Mary Ann Zimmerman; Liliana C Goumnerova; Mark Proctor; R Michael Scott; Karen Marcus; Scott L Pomeroy; Christopher D Turner; Susan N Chi; Christine Chordas; Mark W Kieran
Journal:  J Neurooncol       Date:  2005-03       Impact factor: 4.130

9.  Primary congenital rhabdoid tumor of the brain with neoplastic hydranencephaly.

Authors:  M E Velasco; J A Brown; J Kini; E S Ruppert
Journal:  Childs Nerv Syst       Date:  1993-06       Impact factor: 1.475

10.  Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood.

Authors:  L B Rorke; R Packer; J Biegel
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.